{"filing":{"accession_number":"0001193125-26-241922","cik":"0001811063","ticker":"NUVB","company_name":"Nuvation Bio Inc.","form":"8-K","filing_date":"2026-05-27","report_date":null,"primary_document":"d844566d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1811063/000119312526241922/d844566d8k.htm"},"events":[{"id":8756,"run_id":7685,"accession_number":"0001193125-26-241922","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This Item 5.07 disclosure reports the results of Nuvation Bio's 2026 Annual Meeting of Stockholders held on May 21, 2026, including voting outcomes for three proposals: election of directors (Robert B. Bazemore, Jr., Robert Mashal, M.D., and Kim Blickenstaff), ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents final vote tallies with FOR/AGAINST/WITHHELD/BROKER NON-VOTE counts for each proposal, which is the core disclosure required under Item 5.07.","company_name":"Nuvation Bio Inc.","ticker":"NUVB","filing_date":"2026-05-27","form":"8-K","submitted_at":null,"items":[{"id":1939,"accession_number":"0001193125-26-241922","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the results of Nuvation Bio's 2026 Annual Meeting of Stockholders held on May 21, 2026, including voting outcomes for three proposals: election of directors (Robert B. Bazemore, Jr., Robert Mashal, M.D., and Kim Blickenstaff), ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents final vote tallies with FOR/AGAINST/WITHHELD/BROKER NON-VOTE counts for each proposal, which is the core disclosure required under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-28T02:16:58.234096+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":1939,"accession_number":"0001193125-26-241922","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the results of Nuvation Bio's 2026 Annual Meeting of Stockholders held on May 21, 2026, including voting outcomes for three proposals: election of directors (Robert B. Bazemore, Jr., Robert Mashal, M.D., and Kim Blickenstaff), ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents final vote tallies with FOR/AGAINST/WITHHELD/BROKER NON-VOTE counts for each proposal, which is the core disclosure required under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-28T02:16:58.234096+00:00","company_name":"Nuvation Bio Inc.","ticker":"NUVB","filing_date":"2026-05-27"}]}